Cargando…
Pharmacokinetics of Active Components From Guhong Injection in Normal and Pathological Rat Models of Cerebral Ischemia: A Comparative Study
Background and Objectives: Guhong Injection (GHI) is usually administered for the treatment of stroke in clinics. Aceglutamide and hydroxyl safflower yellow A (HSYA) are its key ingredients for brain protective effect. To investigate the pharmacokinetics of aceglutamide and HSYA under pathological a...
Autores principales: | Yu, Li, Wan, Hao-fang, Li, Chang, Yang, Jie-hong, Zhou, Hui-fen, Wan, Hai-tong, He, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5962683/ https://www.ncbi.nlm.nih.gov/pubmed/29867497 http://dx.doi.org/10.3389/fphar.2018.00493 |
Ejemplares similares
-
Guhong Injection Alleviates Cerebral Ischemia–Reperfusion Injury via the PKC/HIF-1α Pathway in Rats
por: Yu, Li, et al.
Publicado: (2021) -
Guhong Injection Protects Against Apoptosis in Cerebral Ischemia by Maintaining Cerebral Microvasculature and Mitochondrial Integrity Through the PI3K/AKT Pathway
por: Zhou, Huifen, et al.
Publicado: (2021) -
Chemical composition, pharmacology and pharmacokinetic studies of GuHong injection in the treatment of ischemic stroke
por: Wang, Qiuyue, et al.
Publicado: (2023) -
Comparative Pharmacokinetics of Hydrophilic Components in Salvia miltiorrhiza Bge. and Carthamus tinctorius L. in Rats That Underwent Cerebral Ischemia Reperfusion Using an HPLC-DAD Method
por: Zhao, Xixi, et al.
Publicado: (2020) -
Guhong Injection Prevents Ischemic Stroke-Induced Neuro-Inflammation and Neuron Loss Through Regulation of C5ar1
por: Zhang, Jingjing, et al.
Publicado: (2022)